US Physical Therapy Inc
$
120.45
0.49 (0.41%)
| Volume: | 92,078 | Avg Vol (1m): | 91,215 |
| Market Cap $: | 1.54 Bil | Enterprise Value $: | 1.55 Bil |
| P/E (TTM): | 84.23 | P/B: | 6.99 |
| Earnings Power Value | 34.16 |
| Net Current Asset Value | -17.48 |
| Tangible Book | -9.58 |
| Projected FCF | 59.95 |
| Median P/S Value | 52.41 |
| Graham Number | 0 |
| Peter Lynch Value | 10.93 |
| DCF (FCF Based) | 61.68 |
| DCF (Earnings Based) | 15.3 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 7/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.66 |
Cash-To-Debt ranked
higher than
50.00%
of
274
companies
in the
Medical Care
industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
USPH:
0.66
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.17, Med: 0.68, Max: 10000
Current: 0.66
|
| Equity-to-Asset | 0.42 |
Equity-to-Asset ranked
higher than
51.67%
of
269
companies
in the
Medical Care
industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
USPH:
0.42
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: 0.27, Med: 0.65, Max: 0.97
Current: 0.42
|
| Debt-to-Equity | 0.14 |
Debt-to-Equity ranked
higher than
72.28%
of
202
companies
in the
Medical Care
industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
USPH:
0.14
Ranked among companies with meaningful Debt-to-Equity only.
|
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.23, Max: 2.18
Current: 0.14
|
| Debt-to-EBITDA | 0.41 |
Debt-to-EBITDA ranked
higher than
79.10%
of
201
companies
in the
Medical Care
industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
USPH:
0.41
Ranked among companies with meaningful Debt-to-EBITDA only.
|
Debt-to-EBITDA range over the past 10 years
Min: 0.04, Med: 0.63, Max: 0.94
Current: 0.41
|
| Interest Coverage | 33.94 |
Interest Coverage ranked
lower than
70.48%
of
227
companies
in the
Medical Care
industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
USPH:
33.94
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 2.6, Med: 46.45, Max: 140.64
Current: 33.94
|
| Piotroski F-Score | 7 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 4.70 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.73 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 21.49%
WACC 10.44%
| ||
Profitability & Growth : 9/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 13.57 |
Operating Margin ranked
higher than
69.49%
of
272
companies
in the
Medical Care
industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
USPH:
13.57
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: 13.22, Med: 14.16, Max: 15.71
Current: 13.57
|
| Net Margin % | 7.84 |
Net Margin ranked
higher than
57.35%
of
272
companies
in the
Medical Care
industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
USPH:
7.84
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: 4.82, Med: 6.25, Max: 9.06
Current: 7.84
|
| ROE % | 8.55 |
ROE ranked
higher than
60.78%
of
255
companies
in the
Medical Care
industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
USPH:
8.55
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: 7.89, Med: 13.46, Max: 19.88
Current: 8.55
|
| ROA % | 7.94 |
ROA ranked
higher than
64.10%
of
273
companies
in the
Medical Care
industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
USPH:
7.94
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: 5.78, Med: 8.13, Max: 13.79
Current: 7.94
|
| ROC (Joel Greenblatt) % | 219.17 |
ROC (Joel Greenblatt) ranked
higher than
89.34%
of
272
companies
in the
Medical Care
industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
USPH:
219.17
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: 96.79, Med: 124.13, Max: 219.17
Current: 219.17
|
| 3-Year Total Revenue Growth Rate | 11.10 |
3-Year Revenue Growth Rate ranked
higher than
64.45%
of
211
companies
in the
Medical Care
industry.
Industry Max: 314.7, Med: 6.5, Min: -100
USPH:
10.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.1, Med: 12.7, Max: 181.8
Current: 10.3
|
| 3-Year Total EBITDA Growth Rate | 9.20 |
3-Year EBITDA Growth Rate ranked
higher than
58.70%
of
184
companies
in the
Medical Care
industry.
Industry Max: 236.4, Med: 5.9, Min: -108
USPH:
8.4
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.2, Max: 30.9
Current: 8.4
|
| 3-Year EPS w/o NRI Growth Rate | -7.60 |
3-Year EPS w/o NRI Growth Rate ranked
lower than
58.02%
of
162
companies
in the
Medical Care
industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
USPH:
-7.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.6, Max: 127
Current: -7.6
|
» USPH's 30-Y Financials
Financials (Next Earnings Date: 2019-08-02)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:USPH
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Health Care Providers » Medical Care   NAICS : 621498   SIC : 8093 |
| Compare | BKK:SVH SGX:A50 BOM:532843 SGX:BSL BKK:BCH-F ASX:HLS BKK:RAM OHEL:TTALO TSE:7716 SZSE:000950 SZSE:000150 BOM:540975 NAS:TVTY XKLS:5878 XTER:RHK SAU:4004 NYSE:SEM HKSE:01515 TSE:6197 NAS:ADUS |
| Traded in other countries | UPH.Germany |
| Address | 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042 |
| US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 84.23 |
PE Ratio ranked
lower than
79.29%
of
198
companies
in the
Medical Care
industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
USPH:
84.23
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 8.91, Med: 24.55, Max: 88.62
Current: 84.23
|
| Forward PE Ratio | 42.02 |
Forward P/E ranked
lower than
79.66%
of
59
companies
in the
Medical Care
industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
USPH:
42.02
Ranked among companies with meaningful Forward P/E only.
| N/A |
| PE Ratio without NRI | 84.23 |
PE without NRI ranked
lower than
79.80%
of
198
companies
in the
Medical Care
industry.
Industry Max: 6430, Med: 9999, Min: 1.39
USPH:
84.23
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 8.91, Med: 22.4, Max: 88.62
Current: 84.23
|
| Price-to-Owner-Earnings | 38.05 |
Price-to-Owner-Earnings ranked
lower than
61.47%
of
109
companies
in the
Medical Care
industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
USPH:
38.05
Ranked among companies with meaningful Price-to-Owner-Earnings only.
|
Price-to-Owner-Earnings range over the past 10 years
Min: 5.5, Med: 20.65, Max: 40.73
Current: 38.05
|
| PB Ratio | 6.99 |
PB Ratio ranked
lower than
81.03%
of
253
companies
in the
Medical Care
industry.
Industry Max: 48, Med: 2.64, Min: 0.05
USPH:
6.99
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 1.12, Med: 3.04, Max: 7.69
Current: 6.99
|
| PS Ratio | 3.32 |
PS Ratio ranked
lower than
64.89%
of
262
companies
in the
Medical Care
industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
USPH:
3.32
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 0.49, Med: 1.44, Max: 3.64
Current: 3.32
|
| Price-to-Free-Cash-Flow | 24.37 |
Price-to-Free-Cash-Flow ranked
lower than
52.59%
of
135
companies
in the
Medical Care
industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
USPH:
24.37
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
|
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.33, Med: 10.53, Max: 27.32
Current: 24.37
|
| Price-to-Operating-Cash-Flow | 21.51 |
Price-to-Operating-Cash-Flow ranked
lower than
69.35%
of
186
companies
in the
Medical Care
industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
USPH:
21.51
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.83, Med: 9.3, Max: 24.32
Current: 21.51
|
| EV-to-EBIT | 23.97 |
EV-to-EBIT ranked
lower than
50.47%
of
214
companies
in the
Medical Care
industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
USPH:
23.97
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 3.9, Med: 10.9, Max: 28.5
Current: 23.97
|
| EV-to-EBITDA | 20.82 |
EV-to-EBITDA ranked
lower than
60.53%
of
228
companies
in the
Medical Care
industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
USPH:
20.82
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 3.1, Med: 9.55, Max: 24.3
Current: 20.82
|
| EV-to-Revenue | 3.37 |
EV-to-Revenue ranked
lower than
60.52%
of
271
companies
in the
Medical Care
industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
USPH:
3.37
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 0.5, Med: 1.6, Max: 3.7
Current: 3.37
|
| PEG Ratio | 9.84 |
PEG Ratio ranked
lower than
83.51%
of
97
companies
in the
Medical Care
industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
USPH:
9.84
Ranked among companies with meaningful PEG Ratio only.
|
PEG Ratio range over the past 10 years
Min: 0.83, Med: 3.09, Max: 11.35
Current: 9.84
|
| Shiller PE Ratio | 74.02 |
Shiller PE Ratio ranked
lower than
72.58%
of
62
companies
in the
Medical Care
industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
USPH:
74.02
Ranked among companies with meaningful Shiller PE Ratio only.
|
Shiller PE Ratio range over the past 10 years
Min: 12.56, Med: 29.64, Max: 81.33
Current: 74.02
|
| Current Ratio | 1.18 |
Current Ratio ranked
higher than
72.69%
of
260
companies
in the
Medical Care
industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
USPH:
1.18
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
|
| Quick Ratio | 1.18 |
Quick Ratio ranked
higher than
74.62%
of
260
companies
in the
Medical Care
industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
USPH:
1.18
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
|
| Days Sales Outstanding | 38.29 |
Days Sales Outstanding ranked
lower than
59.91%
of
227
companies
in the
Medical Care
industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
USPH:
38.29
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 35.99, Med: 41.85, Max: 47.21
Current: 38.29
|
| Days Payable | 1.94 |
Days Payable ranked
lower than
97.73%
of
176
companies
in the
Medical Care
industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
USPH:
1.94
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 1.94, Med: 2.88, Max: 3.76
Current: 1.94
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 0.82 |
Trailing Dividend Yield ranked
lower than
79.28%
of
251
companies
in the
Medical Care
industry.
Industry Max: 1324.37, Med: 1.79, Min: 0.07
USPH:
0.82
Ranked among companies with meaningful Trailing Dividend Yield only.
|
Trailing Dividend Yield range over the past 10 years
Min: 0.31, Med: 1.17, Max: 1.74
Current: 0.82
|
| Dividend Payout Ratio | 0.67 |
Dividend Payout Ratio ranked
higher than
77.42%
of
155
companies
in the
Medical Care
industry.
Industry Max: 21.34, Med: 0.43, Min: 0.03
USPH:
0.67
Ranked among companies with meaningful Dividend Payout Ratio only.
|
Dividend Payout Ratio range over the past 10 years
Min: 0.2, Med: 0.33, Max: 0.7
Current: 0.67
|
| 3-Year Dividend Growth Rate (Per Share) | 15.30 |
3-Year Dividend Growth Rate ranked
higher than
72.94%
of
85
companies
in the
Medical Care
industry.
Industry Max: 96.1, Med: 8.7, Min: -100
USPH:
15.3
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
|
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 19.3
Current: 15.3
|
| Forward Dividend Yield % | 0.90 |
Forward Dividend Yield ranked
lower than
75.70%
of
251
companies
in the
Medical Care
industry.
Industry Max: 9.57, Med: 1.99, Min: 0.12
USPH:
0.9
Ranked among companies with meaningful Forward Dividend Yield only.
| N/A |
| Yield-on-Cost (5-Year) % | 1.88 |
Yield-on-Cost (5y) ranked
lower than
55.08%
of
325
companies
in the
Medical Care
industry.
Industry Max: 1324.37, Med: 2.24, Min: 0.03
USPH:
1.88
Ranked among companies with meaningful Yield-on-Cost (5y) only.
|
Yield-on-Cost (5y) range over the past 10 years
Min: 0.71, Med: 2.69, Max: 4
Current: 1.88
|
| 3-Year Share Buyback Rate | -0.70 |
3-Year Share Buyback Rate ranked
higher than
96.23%
of
159
companies
in the
Medical Care
industry.
Industry Max: 100, Med: -2.5, Min: -549.3
USPH:
-0.7
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -9.8, Med: -0.9, Max: 7.7
Current: -0.7
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Projected-FCF | 2.01 |
Price-to-Intrinsic-Value-Projected-FCF ranked
higher than
58.42%
of
101
companies
in the
Medical Care
industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
USPH:
2.01
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
|
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.39, Med: 1.02, Max: 9.21
Current: 2.01
|
| Price-to-DCF (Earnings Based) | 7.87 |
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked
lower than
84.85%
of
33
companies
in the
Medical Care
industry.
Industry Max: 6.43, Med: 1.81, Min: 0.5
USPH:
7.87
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
|
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.4, Med: 1.05, Max: 7.3
Current: 7.87
|
| Price-to-Median-PS-Value | 2.30 |
Price-to-Median-PS-Value ranked
lower than
91.83%
of
208
companies
in the
Medical Care
industry.
Industry Max: 12, Med: 1.03, Min: 0.01
USPH:
2.3
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.43, Med: 1.02, Max: 14.08
Current: 2.3
|
| Price-to-Peter-Lynch-Fair-Value | 11.02 |
Price-to-Peter-Lynch-Fair-Value ranked
lower than
92.73%
of
55
companies
in the
Medical Care
industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
USPH:
11.02
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
|
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.47, Med: 1.71, Max: 11.18
Current: 11.02
|
| Earnings Yield (Joel Greenblatt) % | 4.15 |
Earnings Yield (Greenblatt) ranked
higher than
60.44%
of
273
companies
in the
Medical Care
industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
USPH:
4.15
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.5, Med: 9.1, Max: 25.9
Current: 4.15
|
| Forward Rate of Return (Yacktman) % | 10.76 |
Forward Rate of Return ranked
higher than
58.65%
of
133
companies
in the
Medical Care
industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
USPH:
10.76
Ranked among companies with meaningful Forward Rate of Return only.
|
Forward Rate of Return range over the past 10 years
Min: 10.5, Med: 15.1, Max: 26.9
Current: 10.76
|
More Statistics
| Revenue (TTM) (Mil) $ | 461.8 |
| EPS (TTM) $ | 1.43 |
| Beta | 1.38 |
| Volatility % | 33.18 |
| 52-Week Range $ | 93 - 129.65 |
| Shares Outstanding (Mil) | 12.76 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 7 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | Y |